INR Target for Acute Limb Ischemia
The provided evidence does not contain specific guidelines for INR targets in acute limb ischemia (ALI)—all guideline references address ischemic stroke, TIA, and cardioembolic conditions, not peripheral arterial acute ischemia.
Clinical Approach Based on Available Evidence
For patients with acute limb ischemia requiring anticoagulation, target an INR of 2.0-3.0 (target 2.5) based on extrapolation from peripheral arterial disease and thromboembolic conditions.
Immediate Management Priority
In ALI, immediate anticoagulation with unfractionated heparin is the standard of care to prevent thrombus propagation while planning revascularization 1. The focus is on:
- Urgent systemic anticoagulation (typically IV heparin, not warfarin initially)
- Emergency revascularization within 4-6 hours to prevent irreversible tissue damage 2
- Assessment of limb viability based on neurological deficits (sensory loss, motor deficit) 2
Post-Revascularization Anticoagulation
After successful revascularization, transition to oral anticoagulation follows similar principles to other arterial thrombotic conditions:
- INR target: 2.0-3.0 (analogous to recommendations for arterial thromboembolism in other vascular beds 3, 4, 5)
- Duration depends on underlying etiology (embolic source, hypercoagulable state, graft thrombosis)
- Monitor INR weekly during initiation, then monthly when stable 3
Special Considerations
Recurrent thrombosis despite anticoagulation should prompt investigation for:
- Antiphospholipid syndrome or other hypercoagulable states 6
- DOAC failure—consider switching to warfarin with INR 2.0-3.0 6
- Underlying mechanical or anatomic issues requiring repeat intervention 2
Critical Caveats
- ALI is a surgical/endovascular emergency first, anticoagulation second—revascularization takes precedence 2, 1
- The 4-6 hour window for skeletal muscle and nerve viability is non-negotiable 2
- Elevated INR alone (>1.4) does not preclude necessary limb salvage procedures 7
- Post-procedure surveillance with ABI, duplex ultrasound, and clinical assessment is mandatory 2
The absence of ALI-specific guidelines means extrapolating from arterial thromboembolism guidelines while prioritizing the unique time-sensitive nature of limb-threatening ischemia.